- Home
- CLDX vs GRDN Comparison
CLDX vs GRDN Comparison
Compare CLDX & GRDN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CLDX | GRDN |
|---|---|---|
| Founded | N/A | 2004 |
| Country | United States | United States |
| Employees | N/A | 3600 |
| Industry | Biotechnology: In Vitro & In Vivo Diagnostic Substances | Retail-Drug Stores and Proprietary Stores |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.4B | 2.6B |
| IPO Year | 1995 | N/A |
Fundamental Metrics
Financial Performance| Metric | CLDX | GRDN |
|---|---|---|
| Price | $29.27 | $41.48 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 10 | 5 |
| Target Price | ★ $46.60 | $40.60 |
| AVG Volume (30 Days) | ★ 692.1K | 350.6K |
| Earning Date | 05-04-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $12,743,000.00 | N/A |
| Revenue This Year | $111.39 | N/A |
| Revenue Next Year | $235.85 | $7.63 |
| P/E Ratio | ★ N/A | $117.77 |
| Revenue Growth | ★ 87.78 | N/A |
| 52 Week Low | $19.52 | $19.17 |
| 52 Week High | $35.83 | $42.00 |
Technical Indicators
Market Signals| Indicator | CLDX | GRDN |
|---|---|---|
| Relative Strength Index (RSI) | 40.54 | 71.15 |
| Support Level | $28.55 | $31.74 |
| Resistance Level | $30.90 | N/A |
| Average True Range (ATR) | 1.04 | 1.54 |
| MACD | -0.20 | 0.31 |
| Stochastic Oscillator | 22.48 | 93.02 |
Price Performance
Historical ComparisonAbout CLDX Celldex Therapeutics Inc.
Celldex Therapeutics Inc is a biopharmaceutical firm focused on mast cell biology and the development of therapeutic antibodies. Its pipeline includes monoclonal and bispecific antibodies aimed at treating severe inflammatory, allergic, autoimmune, and other mast cell-mediated diseases. The company operates in a single operating and reportable segment in the business of development, manufacturing and commercialization of novel therapeutics for human health care.
About GRDN Guardian Pharmacy Services Inc.
Guardian Pharmacy Services Inc is a pharmacy services company providing technology-enabled services to help residents of long-term health care facilities (LTCFs) adhere to appropriate drug regimens, reducing the cost of care and improving clinical outcomes. The Company provides high-touch clinical, drug dispensing, and administration services tailored to residents in assisted living facilities, behavioral health facilities, and group homes, while also serving residents in all types of LTCFs. It partners with residents, LTCFs, and health plan payors to help reduce errors in drug administration, manage drug regimens, and improve adherence. The Company derives its revenue mainly from the sale of pharmaceutical and medical products.